BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 15166964)

  • 1. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
    Brandt MG; Darling GE; Miller L
    Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
    Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
    DE Carli DM; Araujo AF; Fagundes RB
    Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.
    Postma GN; Tomek MS; Belafsky PC; Koufman JA
    Ann Otol Rhinol Laryngol; 2001 Dec; 110(12):1114-6. PubMed ID: 11768699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender difference in gastro-esophageal reflux diseases.
    Asanuma K; Iijima K; Shimosegawa T
    World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
    Rubenstein JH; Scheiman JM; Sadeghi S; Whiteman D; Inadomi JM
    Am J Gastroenterol; 2011 Feb; 106(2):254-60. PubMed ID: 21139576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.